CBD Life Sciences Inc (CBDL)

[resx18]

Short attack! Loading these cheaps! $CBDL

[JJZander]

Yep. I’m just watching. I didn’t buy.

[packerfan9]

When it goes to .0001. I will laugh at fools who bought and fell for it again.

[JJZander]

Lol

[packerfan9]

The same management is doing more dilution. Same as they have done after every r/s. No one is up that hold shares after all the r/s and how it dropped to .0001. The buys are filled with new shares they sell. Same as before. When they have sold billions again. It will be at .0001. How many times do they have to do this to understand they make more selling shares then ever could selling CBD. A very competitive market.

[JJZander]

OS increased? Looks different from yesterday I believe

[resx18]

We have big news coming tomorrow with some big revenue projections. Also watch for our LOI to be signed very soon for the New York Dispensary’s. We’re exploring our options for a share buyback very soon as well. Stay tuned! $CBDL

— CBD Life Sciences Inc. $CBDL (@CBDL_StockOTC) September 25, 2024

[resx18]

We have big news coming tomorrow with some big revenue projections. Also watch for our LOI to be signed very soon for the New York Dispensary’s. We’re exploring our options for a share buyback very soon as well. Stay tuned!
$CBDL

[resx18]

SCOTTSDALE, AZ / ACCESSWIRE / September 24, 2024 / CBD Life Sciences, Inc. (OTC PINK:CBDL), a leader in innovative cannabidiol products, is thrilled to announce the launch of its flagship product line on Walmart Marketplace. This milestone marks a significant leap in our retail strategy, poised to drive substantial revenue growth and expand our market reach to millions of potential customers.

Key Highlights:

Market Expansion: By entering the Walmart Marketplace, we are now accessible to one of the largest retail platforms in the world, boasting over 120 million monthly visitors. This launch strategically positions CBDL to significantly increase brand visibility and consumer base.

Revenue Growth: Early forecasts project a substantial revenue boost, with a projected increase of 35% in annual sales due to this new distribution channel. Our revenue growth over the past 12 months has already seen a 20% rise, and we expect accelerated growth driven by this expansion.

Product Line on Walmart: The initial offerings will include our top-selling Nano CBD Coffee Creamer, Mellow Mornings, and CBD Pain Cream, which have seen growing demand in local markets. These products, praised for their effectiveness, will now have national distribution, broadening our customer base across the U.S.

Investor Impact: This move opens additional streams of revenue that will enhance shareholder value. By diversifying our sales channels, we aim to increase our gross margins by 10% while driving stronger returns for investors over the next fiscal year.

A Proven Path to Growth
As a small but rapidly growing company, we recognize that entering high-traffic marketplaces like Walmart is a powerful catalyst for scaling. We continue to prioritize innovation in our product lines and have seen positive feedback from both consumers and local retailers. With our products now on Walmart Marketplace, we anticipate a sharper competitive edge and a much larger footprint in the booming CBD sector, which is projected to reach $47.22 billion by 2028.

CEO Statement
"Our launch on Walmart Marketplace represents a monumental step forward in our growth strategy," said Lisa Nelson, CEO of CBD Life Sciences, Inc. "We are not only expanding our reach but enhancing our capacity to deliver value to our investors. The CBD market is poised for explosive growth, and with this new distribution channel, we are strategically positioned to capitalize on the rising consumer demand."

Forward-Looking Growth
CBD Life Sciences remains committed to pursuing additional strategic partnerships and new product launches as we scale. Our focus on innovation, efficiency, and expanding into new revenue streams will be critical to maximizing shareholder value.

[resx18]

Good Morning $CBDL

[RedSox04]

.001 break is close!

[packerfan9]

Wake up. What shares are filling buys? When this is so far down after multiple r/s? It is called dilution same as before. Buying this means losing. Just ask anyone who thought it would do great before the last 2 r/s. This management has done massive dilution now going on for the 3rd time. They get rich selling shares to suckers.

[resx18]

Our press release regarding our Walmart partnership has been released. We will have another exciting release on Thursday! Stay tuned for more updates! $CBDL

— CBD Life Sciences Inc. $CBDL (@CBDL_StockOTC) September 24, 2024

[resx18]

$CBDW selling products

[resx18]

HaHaHa someone missed out on 8's and 9's lmfao

[eqinvestor]

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160549210

I believe you'll see the same pattern. Press releases to dump Reg A stock

[eqinvestor]

All Reg A Stock being sold and YOU KNOW IT

[eqinvestor]

Active Reg A at much lower prices than market price. Would not touch in a million years.

[resx18]

$CBDL sees a substantial revenue boost, with a projected increase of 35% in annual sales due to this new distribution channel. Our revenue growth over the past 12 months has already seen a 20% rise, and we expect accelerated growth driven by this expansion.

[resx18]

$CBDL +33% on 68mm Volume or $60,000 of stock traded so far in 1.5 hours

[BIOCHEMUP]

Nice volume.

[GoonOfWallSt]

This scam still not revoked??? Smh

[i_like_bb_stock]

Yep

[resx18]

$CBDL product is out! #Walmart

[i_like_bb_stock]

walmart news https://www.otcmarkets.com/stock/CBDL/news/CBD-Life-Sciences-Inc-CBDL-Announces-Expanding-Revenue-Stream-With-Walmart-Marketplace?id=453816

[AveragePenny]

$CBDL CBD Life Sciences, Inc. (CBDL) Announces Expanding Revenue Stream With Walmart Marketplace


https://www.accesswire.com/922150/cbd-life-sciences-inc-cbdl-announces-expanding-revenue-stream-with-walmart-marketplace

Walmart's market cap as of September 2024 is $635.50 billion, making it the 13th most valuable company in the world. This partnership offers CBD Life Sciences unprecedented exposure on a global retail platform.

SCOTTSDALE, AZ / ACCESSWIRE / September 24, 2024 / CBD Life Sciences, Inc. (OTC PINK:CBDL), a leader in innovative cannabidiol products, is thrilled to announce the launch of its flagship product line on Walmart Marketplace. This milestone marks a significant leap in our retail strategy, poised to drive substantial revenue growth and expand our market reach to millions of potential customers.

Key Highlights:

Market Expansion: By entering the Walmart Marketplace, we are now accessible to one of the largest retail platforms in the world, boasting over 120 million monthly visitors. This launch strategically positions CBDL to significantly increase brand visibility and consumer base.

Revenue Growth: Early forecasts project a substantial revenue boost, with a projected increase of 35% in annual sales due to this new distribution channel. Our revenue growth over the past 12 months has already seen a 20% rise, and we expect accelerated growth driven by this expansion.

Product Line on Walmart: The initial offerings will include our top-selling Nano CBD Coffee Creamer, Mellow Mornings, and CBD Pain Cream, which have seen growing demand in local markets. These products, praised for their effectiveness, will now have national distribution, broadening our customer base across the U.S.

Investor Impact: This move opens additional streams of revenue that will enhance shareholder value. By diversifying our sales channels, we aim to increase our gross margins by 10% while driving stronger returns for investors over the next fiscal year.

A Proven Path to Growth
As a small but rapidly growing company, we recognize that entering high-traffic marketplaces like Walmart is a powerful catalyst for scaling. We continue to prioritize innovation in our product lines and have seen positive feedback from both consumers and local retailers. With our products now on Walmart Marketplace, we anticipate a sharper competitive edge and a much larger footprint in the booming CBD sector, which is projected to reach $47.22 billion by 2028.

CEO Statement
"Our launch on Walmart Marketplace represents a monumental step forward in our growth strategy," said Lisa Nelson, CEO of CBD Life Sciences, Inc. "We are not only expanding our reach but enhancing our capacity to deliver value to our investors. The CBD market is poised for explosive growth, and with this new distribution channel, we are strategically positioned to capitalize on the rising consumer demand."

[resx18]

$CBDL Announces Expanding Revenue Stream With Walmart Marketplace

https://finance.yahoo.com/news/cbd-life-sciences-inc-cbdl-120000877.html

[packerfan9]

LOL. This will be at .0001 just like after last wo r/s. Just a matter of when.

[RedSox04]

Looking for the .001 break

[resx18]

We will have multiple big news releases this week! We’ve had incredible progress lately and we’re excited to share that with you all! Check OTCmarkets for our next press releases! $CBDL

— CBD Life Sciences Inc. $CBDL (@CBDL_StockOTC) September 23, 2024

[resx18]

Good Morning $CBDL

[packerfan9]

When no one holding shares has a gain. What is filling the buys? The dilution shares same as after each r/s. Buying this is a 100% loss.

[packerfan9]

They really must need to dump a lot of shares. This will again be at .0001.

[tradernewstip]

$CBDL The company is exploring its resources to give horses CBD for pain relief from horse racing and equestrian. Another avenue of revenue for us. More big news coming regarding distribution and acquisitions.

The company is exploring its resources to give horses CBD for pain relief from horse racing and equestrian. Another avenue of revenue for us. More big news coming regarding distribution and acquisitions. $CBDL

— CBD Life Sciences Inc. $CBDL (@CBDL_StockOTC) September 19, 2024

[tradernewstip]

$CBDL is set to launch a cutting-edge nutritional supplement powder designed to harness the powerful health benefits of natural ingredients. This new supplement contains a proprietary blend of reishi mushroom extract, lion's mane mushroom extract, and ashwagandha root extract, offering an integrated approach to wellness by reducing stress, supporting brain health, and enhancing the immune system.
https://finance.yahoo.com/news/cbd-life-sciences-inc-unveils-120000245.html

[packerfan9]

None of it matters. The dilution once again will drive this back to .0001. Same as last two r/s. Wake up. They make more selling shares to suckers. Look at the price. After all the r/s no one is up.

[Clootch]

🌿 Exciting news from CBD Life Sciences, Inc. $CBDL🌿

CBDL has just unveiled a groundbreaking nutritional supplement infused with mushroom extracts! 🍄 This innovative product is set to revolutionize the wellness space, combining the benefits of CBD with the power of mushrooms. With increasing demand for natural health solutions, this could be a major revenue driver for the company and position $CBDL as a leader in holistic wellness.

The future looks bright for both the company and its shareholders! 💥

#CBDL #WellnessRevolution #Innovation #CBD #NutritionalSupplements #RevenueGrowth

[packerfan9]

I never lost a dime here. Only reason I post. I had on a watch list for years. When I see these crooks doing the same after another r/s again. NO reason not to post it is same as before.

[RammageRaul]

Nah Im ok took my losses and moved on :)

[packerfan9]

Wrong you are a bag holder not me. This is is doing the same as after last two r/s. Keep buying you must like being a bag holder.

[tradernewstip]

$CBDL Unveils Groundbreaking Nutritional Supplement Infused With Mushroom Extracts, Set to Drive Revenue and Revolutionize Wellness
Projected to increase company revenue by 20% in the first year, capitalizing on the booming $18 billion wellness market.

SCOTTSDALE, AZ / ACCESSWIRE / September 17, 2024 / CBD Life Sciences, Inc. (CBDL), an innovative leader in the CBD wellness industry, is set to launch a cutting-edge nutritional supplement powder designed to harness the powerful health benefits of natural ingredients. This new supplement contains a proprietary blend of reishi mushroom extract, lion's mane mushroom extract, and ashwagandha root extract, offering an integrated approach to wellness by reducing stress, supporting brain health, and enhancing the immune system.

https://finance.yahoo.com/news/cbd-life-sciences-inc-unveils-120000245.html

[RammageRaul]

Sometimes they never moved on I was bagholding with him when they buried us with the r/s ROFL hes still here whining

[tradernewstip]

$CBDL Barchart https://www.barchart.com/stocks/quotes/CBDL/opinion

[jedijazz]

News; CBDL Projected to increase company revenue by 20% in the first year, capitalizing on the booming $18 billion wellness market.

SCOTTSDALE, AZ / ACCESSWIRE / September 17, 2024 / CBD Life Sciences, Inc. (CBDL), an innovative leader in the CBD wellness industry, is set to launch a cutting-edge nutritional supplement powder designed to harness the powerful health benefits of natural ingredients. This new supplement contains a proprietary blend of reishi mushroom extract, lion's mane mushroom extract, and ashwagandha root extract, offering an integrated approach to wellness by reducing stress, supporting brain health, and enhancing the immune system.


Recent studies highlight the effectiveness of reishi extract, not only in boosting the immune system but also in slowing or stopping tumor growth, a feature that positions this product as an essential addition to the wellness market. The blend of lion's mane extract and ashwagandha root provides additional cognitive support and anti-inflammatory benefits, making it an all-around solution for physical and mental well-being.

Unrivaled Benefits of Key Ingredients:

Reishi Mushroom Extract: Renowned for its immune-boosting and anti-cancer properties, research suggests it can slow tumor growth, making it one of the most potent natural supplements available today.

Lion's Mane Mushroom Extract: Known for supporting brain health, lion's mane helps to enhance cognitive function and promote nerve regeneration, ideal for those seeking long-term mental clarity.

Ashwagandha Root Extract: Widely celebrated for reducing stress and its anti-inflammatory effects, ashwagandha contributes to overall mental health and physical recovery.

Revenue Projections & Market Potential
With the global supplement market experiencing rapid growth, the introduction of this new product is projected to significantly boost CBD Life Sciences, Inc.'s annual revenue. Analysts expect the market for mushroom-infused supplements to reach $18 billion by 2028, and with the unique blend of ingredients in this product, CBD Life Sciences, Inc. is poised to capture a substantial portion of that market. This launch is expected to drive a revenue increase of 20% within the first year, positioning the company at the forefront of the wellness supplement industry.

A Vision for the Future
Lisa Nelson, President and CEO of CBD Life Sciences, Inc., stated, "We are incredibly excited to bring this innovative product to the market. With the growing demand for natural, scientifically backed health solutions, we believe this supplement will be a game-changer, not only for our company but for the health-conscious consumers we serve."

About CBD Life Sciences, Inc.
The CBD Vault Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. The CBD Vault has developed and is retailing/wholesale a full line of cannabidiol based & organic products including, Delta 8 & 10 Gummy's, Full Spectrum Tinctures & Gummy's, Pain Cream, Roll-on's, Salve, Full Pet Line, Pre-Rolls, Full Line of Spa Products, Sleep & Anxiety Edibles. The CBD Vault's products can be viewed and purchased on the Company's website www.thecbdvault.com.

Follow our social media for the latest updates!

X: https://www.x.com/CBDL_StockOTC

Instagram: https://www.instagram.com/cbd.vault

IR Contact: [e-mail]

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information

Lisa Nelson
CEO
[e-mail]
4802091720

Contact Information

Lisa Nelson
CEO
[e-mail]
4802091720

Related Images

SOURCE: CBD Life Sciences Inc.

[AveragePenny]

$CBDL CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused With Mushroom Extracts, Set to Drive Revenue and Revolutionize Wellness

https://www.accesswire.com/918828/cbd-life-sciences-inc-unveils-groundbreaking-nutritional-supplement-infused-with-mushroom-extracts-set-to-drive-revenue-and-revolutionize-wellness

Projected to increase company revenue by 20% in the first year, capitalizing on the booming $18 billion wellness market.

SCOTTSDALE, AZ / ACCESSWIRE / September 17, 2024 / CBD Life Sciences, Inc. (CBDL), an innovative leader in the CBD wellness industry, is set to launch a cutting-edge nutritional supplement powder designed to harness the powerful health benefits of natural ingredients. This new supplement contains a proprietary blend of reishi mushroom extract, lion's mane mushroom extract, and ashwagandha root extract, offering an integrated approach to wellness by reducing stress, supporting brain health, and enhancing the immune system.

Recent studies highlight the effectiveness of reishi extract, not only in boosting the immune system but also in slowing or stopping tumor growth, a feature that positions this product as an essential addition to the wellness market. The blend of lion's mane extract and ashwagandha root provides additional cognitive support and anti-inflammatory benefits, making it an all-around solution for physical and mental well-being.

Unrivaled Benefits of Key Ingredients:

Reishi Mushroom Extract: Renowned for its immune-boosting and anti-cancer properties, research suggests it can slow tumor growth, making it one of the most potent natural supplements available today.

Lion's Mane Mushroom Extract: Known for supporting brain health, lion's mane helps to enhance cognitive function and promote nerve regeneration, ideal for those seeking long-term mental clarity.

Ashwagandha Root Extract: Widely celebrated for reducing stress and its anti-inflammatory effects, ashwagandha contributes to overall mental health and physical recovery.

Revenue Projections & Market Potential
With the global supplement market experiencing rapid growth, the introduction of this new product is projected to significantly boost CBD Life Sciences, Inc.'s annual revenue. Analysts expect the market for mushroom-infused supplements to reach $18 billion by 2028, and with the unique blend of ingredients in this product, CBD Life Sciences, Inc. is poised to capture a substantial portion of that market. This launch is expected to drive a revenue increase of 20% within the first year, positioning the company at the forefront of the wellness supplement industry.

A Vision for the Future
Lisa Nelson, President and CEO of CBD Life Sciences, Inc., stated, "We are incredibly excited to bring this innovative product to the market. With the growing demand for natural, scientifically backed health solutions, we believe this supplement will be a game-changer, not only for our company but for the health-conscious consumers we serve."

[i_like_bb_stock]

news https://www.accesswire.com/918828/cbd-life-sciences-inc-unveils-groundbreaking-nutritional-supplement-infused-with-mushroom-extracts-set-to-drive-revenue-and-revolutionize-wellness

[Clootch]

1. Exciting developments with $CBDL! 🌿 Their recent MOU with a New York dispensary could lead to significant revenue growth and enhance shareholder value. The future looks bright for CBD Life Sciences! 💥 #CBDL #RevenueGrowth #CannabisIndustry

2. Loving the momentum behind $CBDL! With their strategic partnerships and innovative approach in the CBD market, they’re set to make a big impact. Great potential for both growth and value creation here! 🌟 #CBDL #Innovation #GrowthOpportunities

3. Fantastic news for $CBDL investors! Their latest moves in the CBD space are setting them up for exciting growth. The collaboration with a major dispensary in New York is a game changer. Cheers to future success! 🚀 #CBDL #Cannabis #StrategicPartnerships

[packerfan9]

What nonsense. This is the 3rd r/s. Non one is getting back any investment. Same as before it will end up diluted down to .0001. The management gets rich selling shares not CBD. They could never sell enough to just the trillions in dilution basis before 1st r/s. Keep buying they need to sell more shares.
.

[i_like_bb_stock]

https://x.com/CBDL_StockOTC/status/1835681036434325632

[stealofadeal]

$CBDL Anyone buying the Regulation A will push this to get back the most for the investment. This will run for awhile before a drop. News likely from Lisa so likely to run.